RETINALGENIX TECHNOLOGIES INC. Proceeds from Stock Options Exercised
RETINALGENIX TECHNOLOGIES INC. (RTGN) reported Proceeds from Stock Options Exercised of $210.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2026-04-15
- RETINALGENIX TECHNOLOGIES INC. proceeds from stock options exercised for the quarter ending 2024-12-31 was $0.00.
- RETINALGENIX TECHNOLOGIES INC. proceeds from stock options exercised for the quarter ending 2024-09-30 was $0.00.
- RETINALGENIX TECHNOLOGIES INC. proceeds from stock options exercised for the quarter ending 2024-06-30 was $60.00K.
- RETINALGENIX TECHNOLOGIES INC. proceeds from stock options exercised for the quarter ending 2024-03-31 was $150.00K.
- RETINALGENIX TECHNOLOGIES INC. proceeds from stock options exercised for fiscal 2024 was $210.00K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $0.00 derived: sum of 2 quarters · filed 2026-04-15 | $60.00K derived: sum of 3 quarters · filed 2026-04-15 | $210.00K 10-K · filed 2026-04-15 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2025-11-14 | $60.00K derived: sum of 2 quarters · filed 2025-11-14 | $210.00K 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $60.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2025-08-20 | $210.00K 10-Q/A · filed 2025-08-20 | ||
| 2024-03-31 | $150.00K 10-Q · filed 2025-05-15 |